课题基金 / 基金详情

Developing a novel lightweight portable oxygen concentrator unit by validating the performance of the adsorbent materials

Developing a novel lightweight portable oxygen concentrator unit by validating the performance of the adsorbent materials
通过验证吸附材料的性能,开发新型轻型便携式制氧机
批准号:
478248-2015
负责人:
Rohani, Sohrab
金额:
$0.91万
依托单位国家:
加拿大
项目类别:
Engage Plus Grants Program
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

Rohani, Sohrab的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Air pollution is a worldwide epidemic problem particularly in heavily populated megacities. As a result, there is a growing need to address the air quality using a lightweight and portable oxygen concentrator. In this proposal, the industry partner, CPAP Direct Inc. is directly involved in the field of oxygen concentrators for sleep apnea and other medical applications. CPAP is interested in expanding their markets into "portable" air concentrators by developing a product that produces 30-50% oxygen-enriched air, which is not medical grade. The main objective of the research project is to find a suitable zeolitic molecular sieve for the development of a lightweight non-medical grade portable oxygen concentrator. A proper zeolitic molecular sieve working based on pressure swing adsorption (PSA) technique has been identified proven effective in the Engage Grant. This system is capable of producing a 30-50% oxygen-enriched air stream with a flow rate of 2 l/min in a continuous mode. In the next phase of the project, CPAP Direct would continue its support and collaboration with our team to investigate and validate the performance of the selected zeolitic molecular sieves under environmental conditions, and construct a portable oxygen concentrator as a new product. A bench-scale automated PSA setup capable of simulating the actual oxygen concentrator unit under accelerated testing conditions will be investigated in order to evaluate the lifetime of the selected adsorbent and the effect of air pollutants on the unit performance. Furthermore, the control system and the hardware components will be designed with the help of the engineering team of the industrial partner.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Experimental and computational studies of pharmaceuticals crystallization
  • 批准号:
    RGPIN-2021-03595
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.35万
  • 财政年份:
    2022
  • 负责人:
    Rohani, Sohrab
  • 依托单位:
Experimental and computational studies of pharmaceuticals crystallization
  • 批准号:
    RGPIN-2021-03595
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $3.35万
  • 财政年份:
    2021
  • 负责人:
    Rohani, Sohrab
  • 依托单位:
Crystallization of Pharmaceuticals, Design, Control, and Delivery
  • 批准号:
    RGPIN-2016-04445
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.77万
  • 财政年份:
    2020
  • 负责人:
    Rohani, Sohrab
  • 依托单位:
Crystallization of Pharmaceuticals, Design, Control, and Delivery
  • 批准号:
    RGPIN-2016-04445
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.77万
  • 财政年份:
    2019
  • 负责人:
    Rohani, Sohrab
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: